
### [NCIT:C27262](http://purl.obolibrary.org/obo/NCIT_C27262)
**Label:** Myelodysplastic/Myeloproliferative Neoplasm

**Subclasses:** [NCIT:C82616](http://purl.obolibrary.org/obo/NCIT_C82616) (Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis), [NCIT:C3178](http://purl.obolibrary.org/obo/NCIT_C3178) (Chronic Myelomonocytic Leukemia), [NCIT:C36062](http://purl.obolibrary.org/obo/NCIT_C36062) (Chronic Myelomonocytic Leukemia-2), [NCIT:C130035](http://purl.obolibrary.org/obo/NCIT_C130035) (Chronic Myelomonocytic Leukemia-0), [NCIT:C27780](http://purl.obolibrary.org/obo/NCIT_C27780) (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable), [NCIT:C82397](http://purl.obolibrary.org/obo/NCIT_C82397) (Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm), [NCIT:C3519](http://purl.obolibrary.org/obo/NCIT_C3519) (Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative), [NCIT:C36061](http://purl.obolibrary.org/obo/NCIT_C36061) (Chronic Myelomonocytic Leukemia-1), [NCIT:C9233](http://purl.obolibrary.org/obo/NCIT_C9233) (Juvenile Myelomonocytic Leukemia), [NCIT:C36060](http://purl.obolibrary.org/obo/NCIT_C36060) (Chronic Myelomonocytic Leukemia with Eosinophilia), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma))) 39.90%


